<DOC>
	<DOCNO>NCT00829049</DOCNO>
	<brief_summary>Comparison safety efficacy Tazarotene Cream 0.1 % compare Adapalene Gel 0.3 % treat moderate severe facial acne vulgaris</brief_summary>
	<brief_title>Safety Efficacy Tazarotene Cream 0.1 % Compared With Adapalene Gel 0.3 % Treatment Moderate Severe Facial Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Facial acne vulgaris characterize follow : 25100 facial inflammatory lesion ( papule plus pustule ) ; 40 noninflammatory lesion ( open/closed comedo ) ) ; stable disease , nonrapidly regress facial acne vulgaris ; , 3 less facial nodule and/or cyst ( diameter 1cm great ) . Female subject childbearing potential must negative urine pregnancy test baseline practice reliable method contraception throughout study . Noncompliance washout period Skin disease/disorder might interfere diagnosis evaluation acne vulgaris Allergy sensitivity component test medication Cosmetic surgical procedure complementary treatment facial acne within 14 day baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>